917980-15-5 Usage
Description
6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzo[d]imidazole-5-carbonitrile, commonly referred to as BCFI, is a complex organic compound characterized by a benzo[d]imidazole ring with multiple substituents. It features a bromine atom, a chlorine atom, and a fluorine atom, along with a carbonitrile group, which is often associated with medicinal and pharmaceutical applications. The structural complexity and functional groups present in BCFI suggest that it may possess biological activity, making it a promising candidate for the development of new pharmaceutical agents.
Uses
Used in Pharmaceutical Development:
BCFI is used as a starting point for the development of new pharmaceutical agents due to its complex molecular structure and the presence of a carbonitrile group, which is commonly found in drugs and biologically active compounds. Its potential biological activity and unique structural features make it a valuable compound for further research and testing to explore its properties and possible applications in medicine.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, BCFI serves as a valuable compound for studying the relationship between molecular structure and biological activity. Its benzo[d]imidazole ring and multiple substituents, including the bromine, chlorine, and fluorine atoms, provide opportunities for investigating the effects of these functional groups on the compound's interactions with biological targets and its overall pharmacological profile.
Used in Drug Design and Optimization:
BCFI's structural features and potential biological activity make it a useful compound for drug design and optimization efforts. Researchers can use BCFI as a template to modify and improve its properties, such as potency, selectivity, and pharmacokinetics, through medicinal chemistry techniques. This process can lead to the development of more effective and safer pharmaceutical agents.
Used in Drug Discovery:
BCFI's potential as a starting point for the development of new pharmaceutical agents makes it a valuable compound for drug discovery initiatives. By screening and evaluating BCFI's biological activity against various targets, researchers can identify its potential therapeutic applications and guide the optimization of its structure to enhance its efficacy and safety.
Used in Chemical Synthesis:
The synthesis of BCFI and its analogs can contribute to the development of new chemical methodologies and synthetic routes. The presence of multiple functional groups in its structure provides opportunities for exploring novel synthetic strategies and reactions, which can be applied to the preparation of other complex organic compounds with potential applications in various fields, including pharmaceuticals, materials science, and agrochemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 917980-15-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,9,8 and 0 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 917980-15:
(8*9)+(7*1)+(6*7)+(5*9)+(4*8)+(3*0)+(2*1)+(1*5)=205
205 % 10 = 5
So 917980-15-5 is a valid CAS Registry Number.
917980-15-5Relevant articles and documents
SNAr PROCESS FOR PREPARING BENZIMIDAZOLE COMPOUNDS
-
Page/Page column 55-56, (2010/11/25)
Provided are methods for the synthesis of heterocyclic compounds such as benzimidazole carboxylic acid core structures having Formula Ia-2 and their synthetic intermediates: wherein X1, X2, X5, R1, R2 and R4 are as defined herein. Compounds of Formula Ia-2 and their synthetic intermediates can be used to prepare heterocyclic derivatives such as benzimidazole derivatives.
